EP1349649A2 - Procede de sequencage par molecule individuelle - Google Patents

Procede de sequencage par molecule individuelle

Info

Publication number
EP1349649A2
EP1349649A2 EP01947427A EP01947427A EP1349649A2 EP 1349649 A2 EP1349649 A2 EP 1349649A2 EP 01947427 A EP01947427 A EP 01947427A EP 01947427 A EP01947427 A EP 01947427A EP 1349649 A2 EP1349649 A2 EP 1349649A2
Authority
EP
European Patent Office
Prior art keywords
nucleic acid
microchannel
carrier particle
acid molecule
building blocks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01947427A
Other languages
German (de)
English (en)
Inventor
Zeno Clinical Immunology FÖLDES-PAPP
Johan Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gnothis Holding SA
Original Assignee
Gnothis Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10065626A external-priority patent/DE10065626A1/de
Application filed by Gnothis Holding SA filed Critical Gnothis Holding SA
Publication of EP1349649A2 publication Critical patent/EP1349649A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing

Definitions

  • the invention relates to a method for single-molecule sequencing of nucleic acids and a device suitable for carrying out the method.
  • the sequencing of the human genome consisting of approx. 3 x 10 9 bases or the genome of other organisms and the determination and comparison of individual sequence variants requires the provision of sequencing methods which are fast on the one hand and can be used routinely and at low cost on the other hand.
  • sequencing methods for example the enzymatic chain termination method according to Sanger et al. (Proc. Natl. Acad. Sci. USA 74 (1977) 5463), in particular by automation (Adams et al., Automated DNA Sequencing and Analysis (1994), New York, Academic Press) can currently only have a maximum of 2,000 bases can be determined per day with a sequencer.
  • Another approach is single-molecule sequencing (Dörre et al., Bioimaging 5 (1997), 139-152), in which the sequence of nucleic acids is carried out by the progressive enzymatic degradation of fluorescence-labeled single-stranded DNA molecules and detection of the sequentially released monomer molecules in a microstructure channel, in which the monomer molecules are guided electroosmotically by pumps.
  • the advantage of this method is that only a single molecule of the target nucleic acid is sufficient to carry out a sequence determination.
  • the method according to the invention is a sequencing method in which a single nucleic acid molecule immobilized on a carrier is examined.
  • the carrier particle used for the process has a size that allows movement in microchannels and adherence to a desired one
  • the particle size is preferably in the range from 0.5 to 10 ⁇ m and particularly preferably from 1 to 3 // m.
  • suitable materials for carrier particles are
  • Plastics such as polystyrene, glass, quartz, metals or semi-metals such as
  • Optically transparent carrier particles for example made of plastics or particles with a plastic core and one, are particularly preferred
  • Silicon dioxide shell used.
  • the nucleic acid molecules are preferably immobilized on the carrier particle via their 5 'ends.
  • the nucleic acid molecules can be bound to the support by covalent or non-covalent interactions.
  • the binding of the polynucleotides to the carrier can be mediated by high-affinity interactions between the partners of a specific binding pair, for example biotin / streptavidin or avidin, hapten / anti-hapten antibodies, sugar / lectin etc.
  • biotinylated nucleic acid molecules can be coupled to streptavidin-coated supports.
  • the nucleic acid molecules can also be bound to the support by adsorption.
  • Carrier particles to which only a single nucleic acid molecule is bound are used for the method according to the invention.
  • Such carrier particles can be produced in that the nucleic acid molecules provided for sequencing in a molar ratio of preferably 1: 5 to 1:20, e.g. 1:10, are brought into contact with the carrier particles under conditions in which the nucleic acid molecules are immobilized on the carrier.
  • the resulting carrier particles are then, e.g. B. sorted on the basis of the fluorescent marker groups contained on the nucleic acid molecules and separated from particles to which no nucleic acid molecule is bound. This sorting and separation can, for example, according to the in Holm et al.
  • nucleic acid molecules bound to a carrier can be in single-stranded or double-stranded form. In the case of double-stranded molecules, it must be ensured that labeled nucleotide building blocks can only be split off from a single strand.
  • a carrier for example DNA molecules or RNA molecules
  • essentially all, for example at least 90%, preferably at least 95% of all nucleotide building blocks of at least one base type carry a fluorescent labeling group.
  • essentially all nucleotide building blocks of at least two base types carry for example two, three or four base types, a fluorescent label, each base type advantageously carrying a different fluorescent label group.
  • Nucleic acids marked in this way can be obtained by enzymatic primer extension on a nucleic acid matrix using a suitable polymerase, for example a DNA polymerase such as a DNA polymerase from Thermococcus gorgonarius or other thermostable organisms (Hopfner et al., PNAS USA 96 (1999), 3600 -3605) or a mutated Taq polymerase (Patel and Loeb, PNAS USA 97 (2000), 5095-510) using fluorescence-labeled nucleotide building blocks.
  • the labeled nucleic acid strands can also be produced by amplification reactions, for example PCR.
  • asymmetrical amplification products in which only a single strand contains fluorescent labels.
  • Such asymmetrical amplification products can be sequenced in double-stranded form.
  • Nucleic acid fragments in which both strands are fluorescence-labeled are produced by symmetrical PCR. These two fluorescence-labeled strands can be separated and immobilized separately in single-stranded form on carrier particles, so that the sequence of one or both complementary strands can be determined separately.
  • one of the two strands at the 3 'end can be modified in this way, for example by installing a PNA clamp, so that it is no longer possible to split off monomer units. In this case, double-strand sequencing is possible.
  • a "sequence identifier" ie a labeled nucleic acid of known sequence
  • a "sequence identifier" ie a labeled nucleic acid of known sequence
  • the nucleic acid template the sequence of which is to be determined, can be selected, for example, from DNA templates such as genomic DNA fragments, cDNA molecules, plasmids etc., but also from RNA templates such as mRNA molecules.
  • the fluorescent labeling groups can be from known for labeling Bi o p o l ym e re n, z.
  • Step (b) comprises introducing a loaded carrier particle into a sequencing device with a microchannel.
  • a capture laser e.g. an IR laser
  • the carrier particle can be held in a capillary or a microchannel according to process step (c).
  • a capture laser e.g. an IR laser
  • Such methods are described, for example, by Ashkin et al. (Nature 330 (1987), 24-31) and Chu (Science 253 (1991), 861-866).
  • the carrier particle is preferably held in place by an automated process.
  • the carrier particles are passed through the microchannel in the hydrodynamic flow, passing through a detection element.
  • the detector in the detection window is set in such a way that it recognizes a marked sphere on the basis of the fluorescence-marked D NA and / or an additional fluorescence-marked probe, and then automatically activates the capture laser in the measuring room.
  • Carrier particles that the detector does not classify as positive are passed through. After capturing a carrier particle, the sorting process is stopped and the remaining carrier particles are washed away. The sequencing reaction is then carried out on the immobilized carrier particle.
  • the sequencing reaction of the method according to the invention comprises the progressive cleavage of individual nucleotide building blocks from the immobilized nucleic acid molecules.
  • An enzymatic cleavage is preferably carried out using an exonuclease, single-strand or double-strand exonucleases which degrade in the 5 ' ⁇ 3' direction or in the 3 '- * 5' direction - depending on the type of immobilization of the nucleic acid strands on the support - can be used.
  • T7 DNA polymerase, E. coli exonuclease I or E. coli exonuclease III are particularly preferably used as exonucleases.
  • the invention is based on the fact that the nucleotide building blocks released by the cleavage reaction are passed through a microchannel by means of a hydrodynamic flow and are determined during the flow through the microchannel.
  • the hydrodynamic flow enables an increase in the flow speed, which in turn leads to an increase in the detection probability of a nucleotide building block.
  • the occurrence of wall effects compared to the electroosmotic pumps known from the prior art can be reduced by the hydrodynamic flow, which is generated, for example, by suction or application of pressure.
  • the hydrodynamic flow through the microchannel preferably has a parabolic flow profile, ie the flow rate is at a maximum in the center of the microchannel and decreases in a parabolic function towards the edges to a minimum speed.
  • the maximum flow rate through the microchannel is preferably in the range from 1 to 50 mm / s, particularly preferably in the range from 5 to 10 mm / s.
  • the diameter of the microchannel is preferably in the range from 1 to 100 ⁇ m, particularly preferably from 10 to 50 ⁇ m.
  • the measurement is preferably carried out in a linear microchannel with a substantially constant diameter.
  • the identification of fluorescence-labeled nucleotide building blocks according to step (e) of the method according to the invention can be carried out by means of any measurement method, for example with a location- and / or time-resolved fluorescence spectroscopy, which is capable of in a very small volume element such as is present in a microchannel. Capture fluorescence signals down to single photon count.
  • the detection can be carried out by means of confocal single-molecule detection, such as by fluorescence correlation spectroscopy, with a very small, preferably confocal volume element, for example 0.1 x 10 "15 to 20 x 10 " 12 I, of the sample liquid flowing through the microchannel emitting an excitation light Is exposed to the laser, which excites the receptors located in this measurement volume to emit fluorescent light, the emitted fluorescent light from the measurement volume being measured by means of a photodetector, and establishing a correlation between the temporal change in the measured emission and the relative flow rate of the molecules involved, so that individual molecules can be identified in the measurement volume when diluted accordingly.
  • confocal single-molecule detection such as by fluorescence correlation spectroscopy
  • the detection can also be carried out by a time-resolved decay measurement, a so-called time gating, as described, for example, by Rigler et al., "Picosecond Single Photon Fluorescence Spetroscopy of Nucleic Acids", in: “Ultrafast Phenomenes”, DH Auston, Ed. , Springer 1984.
  • the fluorescence molecules are excited within a measurement volume and then - preferably at a time interval of> 100 ps - the opening of a detection interval at the photodetector. In this way, background signals generated by Raman effects can be kept sufficiently low to enable essentially interference-free detection.
  • the detection is carried out using a laser device which has a diffraction element or a phase-modulating element in the beam path of the laser, which is optionally configured in combination with one or more optical imaging elements to produce a diffraction pattern in the form of a generate linear or two-dimensional arrays of focal areas in the microchannel, the optical arrangement being set up to confocally image each focal area for fluorescence detection by the photodetector arrangement.
  • the detection device is integrated in two walls of the microchannel delimiting one another, one wall having an array of laser elements emitting into the microchannel as fluorescent excitation light source and the other having an array of photodetector elements assigned to the laser elements as fluorescent light detectors ,
  • the hydrodynamic flow profile in the microchannel of the sequencing device achieves an increase in the probability of detection of nucleotide components, which is essential to the invention, and thus an improvement in sensitivity.
  • the hydrodynamic flow in the microchannel can be set and regulated by suitable electronic control devices.
  • electrophoretic and electroosmotic methods for the transport of reagents can also be used in the sequencing device.
  • the method according to the invention also allows the parallel one Sequence of several carrier particle-bound nucleic acid molecules in different, preferably parallel microchannels.
  • the nucleic acid coupled to a carrier particle is held essentially in the center of the microchannel, the cleaved fluorescence-labeled nucleotides are conducted downstream in a laminar flow to a detection volume element, which is positioned essentially in the center of the channel, where the highest flow rate prevails is.
  • the flow rate is preferably so great that, regardless of the thermal broadening of the flow trajectories by Brownian diffusion, the nucleotide arrives in the detector field and is registered.
  • the detector field is kept as small as possible so that the nucleotide bases are completely detected, while only a minimal fraction of the background contamination (ratio of the detector cross section to the channel cross section) occurs in the detector.
  • Another object of the invention is a device for sequencing an analyte in a sample liquid, comprising:
  • the device preferably also contains automatic manipulation devices, heating or cooling devices such as Peltier elements, means for sorting carrier particles, reservoirs and optionally supply lines for sample liquid and reagents, and electronic evaluation devices.
  • automatic manipulation devices heating or cooling devices such as Peltier elements, means for sorting carrier particles, reservoirs and optionally supply lines for sample liquid and reagents, and electronic evaluation devices.
  • the device is particularly suitable for carrying out the method according to the invention.
  • Yet another embodiment of the invention relates to a method for single molecule sequencing using only two fluorescent labels.
  • the invention thus relates to a method for sequencing nucleic acids, comprising the steps:
  • At least two carrier particles are provided with nucleic acid molecules immobilized thereon, which have at least partially overlapping sequences and in which the two fluorescent labels used for the two-color sequencing are each assigned to different bases or / and base combinations.
  • a first fluorescent label can be assigned to two bases B T and B 2 and a second fluorescent label to two bases B 3 and B 4 on a carrier particle, a first fluorescent label to two bases B-, and B 3 and a second fluorescent label is assigned to two bases B 2 and B 4 and, if appropriate, a first fluorescent label is assigned to two bases B, and B 4 and a second fluorescent label to two bases B 2 and B 3 on a third carrier particle.
  • BB 2 , B 3 and B 4 each represent the four bases which occur in the nucleic acid to be sequenced, ie usually A, G, C and T.
  • a first fluorescent label is assigned to a base B. and a second fluorescent label is assigned to three bases B 2 , B 3 and B 4 on a first carrier particle, a first fluorescent label is assigned to a base B 2 and a second to a second carrier particle Fluorescent labeling assigned to three bases BB 3 and B 4 , a first fluorescent label each assigned to a base B 3 on a third carrier particle and a second fluorescent label assigned to three bases B 1 f B 2 and B 4 and a first fluorescent label each to a base B 4 on a fourth carrier particle and a second fluorescent label assigned to three bases B 17 B 2 and B 3 .
  • a first fluorescent label is assigned to two bases on a first carrier particle and a second fluorescent label is assigned to the two other bases and on one second carrier particles assigned a first fluorescent label of a base and a second fluorescent label to the three other bases.
  • further carrier particles with other 2/2 or / and 1/3 combinations can optionally be used.
  • a complete determination of the base sequence of a DNA sequence can also be obtained using only 2 fluorescent labeling groups with different spectroscopic properties, such as emission wavelength or / and lifetime of the excited state.
  • 2 fluorescent labeling groups with different spectroscopic properties, such as emission wavelength or / and lifetime of the excited state.
  • two nucleotide bases are provided with a first labeling group and the other two nucleotide bases are provided with a second labeling group.
  • the nucleic acid to be sequenced is marked in a parallel approach in such a way that other base combinations are each provided with the same labeling group.
  • An example of this embodiment is shown below:
  • a sequence can be obtained if AT, AC or AG are in one color and CG, GT or CT in another color (see combinations 1, 2 and 3).
  • To obtain the complete base sequence it is sufficient to sequence the color combinations 1 and 2, 2 and 3 or 1 and 3.
  • a combination of 1, 2 and 3 is not absolutely necessary. In order to reduce the probability of errors, such a combination of 3 approaches is sometimes useful.
  • a complete sequence can be determined using two dual base / fluorescent label combinations. However, a single dual combination may be sufficient for certain types of sequences, for example for determining mutations.
  • a combination of the dual color combinations (e.g. two green and two red bases) with a single color combination (e.g. one green base and 3 red bases) is also interesting for certain embodiments.
  • the invention further relates to a method for sorting particles in a microchannel, comprising the steps:
  • a trapping laser for example, an IR laser
  • a trapping laser is activated and is not activated on the particles of the trapping laser, in the absence of the predetermined parameter ⁇ ,
  • the detection element and / or the measuring element are preferably confocal volume elements, the detection element being arranged upstream of the measuring element in the microchannel.
  • Measuring the captured particle can include, for example, sequencing as previously described.
  • Figure 1 shows a section of a device for performing the method according to the invention.
  • a carrier particle (4) is held in a microchannel (2) by means of a capture laser (6).
  • a nucleic acid molecule (8) is immobilized on the carrier particle (4), from which individual nucleotide building blocks (1 0) are cleaved sequentially by enzymatic digestion and transported from a hydrodynamic flow through the microchannel to a detection element (1 2), preferably a confocal detection element, and there be detected.
  • the liquid flowing through the microchannel contains the enzyme used to digest the immobilized nucleic acid molecule, preferably an exonuclease.
  • the flow rate through the microchannel is set so that the broadening of the migration path of the split-off nucleotide building blocks caused by Brownian molecular motion is so small that they can be detected with sufficient statistical probability in the detection volume (1 2).
  • the device 2 shows a larger section of the device according to the invention, comprising the section (20a) of the microchannel (20) shown in FIG. 1 with the capturing laser and the confocal detection element (not shown here).
  • the device also contains a feed opening (22) and a drain opening (28) for liquid, for example solvent, between which the hydrodynamic flow in the microchannel (20) is generated by applying pressure or suction.
  • the device also contains an opening for supplying carrier particles (24) and an opening for Enzyme feed (26).
  • the enzyme and carrier particles can optionally be introduced by electroosmotic flow, a negative electrode being applied at (24) and (26) and a positive electrode at (28).
  • the hydrodynamic flow through the microchannel (20) can take place by means of electronically controlled pumps, which can be located outside the microstructure, but can also be integrated therein.
  • carrier particles are passed through the opening (24) into the channel (20).
  • a single carrier particle that is loaded with a nucleic acid molecule is held in place by the capture laser. Other particles and contaminants are washed away.
  • Enzyme is then added through the opening (26) and the sequencing reaction is carried out. After the sequencing is complete, the carrier particle is rinsed out of the microchannel. Then another sequencing cycle can be carried out with a new microparticle.
  • This procedure can be automated using appropriate electronic control devices.
  • the device can contain several microchannels for the parallel sequencing of several carrier particles.
  • FIG. 3 shows a preferred embodiment of an inventive device for single molecule sequencing.
  • This device comprises a carrier with at least 6 openings for microfluidic channels.
  • the opening (2) serves to supply the sample or the microparticles contained therein and, if appropriate, a buffer.
  • the opening (4) serves to supply the exonuclease.
  • the opening (6) is provided for discharging used solution from the carrier.
  • the openings (8) and (12) are also provided for discharging used solutions from the carrier.
  • the opening (10) serves to supply buffer.
  • the device can also contain further openings for the supply or discharge of liquids.
  • the diameter of the microfluidic channels within the carrier is preferably those for the feed line provided channels in the range of 40-80 microns, especially about 50 microns.
  • the discharge channels can have a considerably larger diameter, for example up to 500 ⁇ m. The broadening of the diameter can take place immediately after the intersection of the channels and serves to improve the control and to increase the stability within the system.
  • the microparticle introduced into the device through the opening (2) is first captured in the area of position (20), e.g. by an IR laser, while the transport liquid is guided out of the carrier again through opening (8).
  • the captured microparticle is then transported to position 22 within the carrier, e.g. by a flow of liquid and / or by an IR laser where it is held again, e.g. by an IR laser, and then subjected to enzymatic degradation.
  • enzyme is passed through the opening (4) to the position (22) with the held microparticle and then transported out of the device through the opening (12).
  • the nucleotides released by the enzymatic degradation of the nucleic acid on the microparticle at position (22) are detected downstream at position (24).
  • the buffer can be introduced into the device through the opening (10) and out again through the openings (8) and / or (12).
  • the enzyme in the device is flushed out through opening (12) and at the same time prevents a new microparticle, e.g. at position (20), comes into premature contact with the enzyme.
  • an electrical field can be created in the channels, for example via a positive electrode in the area of position (24) and a negative electrode in the area of opening (2). That way, the on stretched DNA to be sequenced immobilized on the microparticle and thus made more accessible for enzymatic treatment.
  • Reservoirs are provided for the liquids to be introduced into the device or the liquids derived from the device.
  • the invention thus furthermore relates to a device for sequencing nucleic acids, comprising: (a) an optically transparent microchannel,
  • this device comprises:
  • Communication microchannels (b) an opening (2) for introducing a carrier particle with a nucleic acid molecule immobilized thereon in a microchannel, essentially all nucleotide building blocks of at least a base type in at least one strand of the nucleic acid molecule carry a fluorescent label, (c) an opening (4) for introducing a nucleic acid-degrading enzyme into a microchannel, (d) a plurality of openings (6, 8, 12) for discharging liquid from the carrier .
  • the carrier has means for transporting the particle containing the nucleic acid to be sequenced from a first predetermined position, the capture position, to a second predetermined position, the degradation position.
  • the sequential operation of the device i.e. the analysis of several particles in a row, facilitated, in particular because in the capture position, contact with the nucleic acid-degrading enzyme can be better prevented.
  • Microchannels in the device according to the invention preferably have a larger diameter to the discharge openings, preferably an at least 1.5 times larger diameter than microchannels to the inlet openings.
  • the flow within the device is preferably a hydrodynamic flow. It is further preferred that means for Application of an electric field between the second predetermined position and the first predetermined position are provided.
  • the invention relates to a method for sequencing nucleic acids using a device as described above.
  • This method preferably comprises the steps:

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé de séquençage par molécule individuelle d'acides nucléiques et un dispositif approprié pour mettre ledit procédé en oeuvre.
EP01947427A 2000-06-30 2001-06-29 Procede de sequencage par molecule individuelle Withdrawn EP1349649A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10031840 2000-06-30
DE10031840 2000-06-30
DE10065626A DE10065626A1 (de) 2000-06-30 2000-12-29 Einzelmolekül-Sequenzierungsverfahren
DE10065626 2000-12-29
PCT/EP2001/007460 WO2002002225A2 (fr) 2000-06-30 2001-06-29 Procede de sequençage par molecule individuelle

Publications (1)

Publication Number Publication Date
EP1349649A2 true EP1349649A2 (fr) 2003-10-08

Family

ID=26006237

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01947427A Withdrawn EP1349649A2 (fr) 2000-06-30 2001-06-29 Procede de sequencage par molecule individuelle

Country Status (4)

Country Link
US (1) US20050153284A1 (fr)
EP (1) EP1349649A2 (fr)
AU (1) AU2001269109A1 (fr)
WO (1) WO2002002225A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003046216A1 (fr) * 2001-11-27 2003-06-05 Gnothis Holding Sa Nanostructure, notamment pour analyser des molecules individuelles
JP5452922B2 (ja) * 2005-09-13 2014-03-26 アフィメトリックス・インコーポレーテッド コード化されたマイクロ粒子
WO2009020682A2 (fr) 2007-05-08 2009-02-12 The Trustees Of Boston University Fonctionnalisation chimique d'ensembles de nanopores et de nanopores à semi-conducteurs, et leurs applications
WO2008147879A1 (fr) * 2007-05-22 2008-12-04 Ryan Golhar Procede et dispositif automatises d'identification et d'isolement d'adn et de definition de sequences
WO2011040996A1 (fr) 2009-09-30 2011-04-07 Quantapore, Inc. Séquençage ultrarapide de polymères biologiques au moyen de nanopores marqués
ES2683707T3 (es) * 2012-05-02 2018-09-27 Ibis Biosciences, Inc. Secuenciación de ADN
US9651539B2 (en) 2012-10-28 2017-05-16 Quantapore, Inc. Reducing background fluorescence in MEMS materials by low energy ion beam treatment
EP3004385B1 (fr) 2013-05-24 2018-11-28 Quantapore Inc. Analyse d'acides nucléiques basés sur des nanopores avec une détection par fret mixte
CA2963604C (fr) 2014-10-10 2023-02-14 Quantapore, Inc. Analyse de polymeres, a base de nanopore, a l'aide de marqueurs fluorescents a desactivation mutuelle
CN107002126B (zh) 2014-10-24 2021-05-25 昆塔波尔公司 使用纳米结构阵列的聚合物的高效光学分析
JP2019522983A (ja) 2016-07-05 2019-08-22 クアンタポール， インコーポレイテッド 光学ベースのナノポア配列決定

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962037A (en) * 1987-10-07 1990-10-09 United States Of America Method for rapid base sequencing in DNA and RNA
US5405747A (en) * 1991-09-25 1995-04-11 The Regents Of The University Of California Office Of Technology Transfer Method for rapid base sequencing in DNA and RNA with two base labeling
CA2155186A1 (fr) * 1993-02-01 1994-08-18 Kevin M. Ulmer Methodes et appareil pour le sequencage de l'adn
CA2333201A1 (fr) * 1998-05-22 1999-12-02 California Institute Of Technology Trieur de cellules microfabrique
DE19844931C1 (de) * 1998-09-30 2000-06-15 Stefan Seeger Verfahren zur DNS- oder RNS-Sequenzierung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GÖSCH ET AL.: "HYDRODYNAMIC FLOW PROFILING IN MICROCHANNEL STRUCTURES BY SINGLE MOLECULE FLUORESCENCE CORRELATION SPECTROSCOPY", ANALYTICAL CHEMISTRY, vol. 72, no. 14, 10 June 2000 (2000-06-10), COLUMBUS, US, pages 3260 - 3265, XP002180726 *

Also Published As

Publication number Publication date
AU2001269109A1 (en) 2002-01-14
US20050153284A1 (en) 2005-07-14
WO2002002225A2 (fr) 2002-01-10
WO2002002225A3 (fr) 2003-04-24
WO2002002225A9 (fr) 2003-08-07

Similar Documents

Publication Publication Date Title
DE60012511T2 (de) Mikrofluidische systeme mit mikrokugelmatrizen zum nachweis von zielanalyten
WO2002038806A2 (fr) Identification de polymorphismes d'acide nucleique
DE60018733T2 (de) Vorrichtung und verfahren zur probenanalyse
EP1629116B1 (fr) Procede de detection de mutations ponctuelles d'adn (analyse de pns) et systeme associe
EP1975246A1 (fr) Séquençage sans marquage sur une surface solide en utilisant un transitor à effet de champ
DE112005000293T5 (de) Gendetektions-Feldeffektvorrichtung und Verfahren zum Analysieren einer Genpolymorphie damit
EP1349649A2 (fr) Procede de sequencage par molecule individuelle
DE10214395A1 (de) Verfahren zur Analyse von Einzelnukleotidpolymorphismen
WO2002097406A1 (fr) Utilisation d'elements de diffraction optiques dans des procedes de detection
EP1294946B1 (fr) PROCEDE DE SEQUENçAGE MULTIPLEX
WO2003046216A1 (fr) Nanostructure, notamment pour analyser des molecules individuelles
EP1303353B1 (fr) Procede et dispositif d'analyse d'echantillons chimiques ou biologiques
WO2003052136A2 (fr) Sequençage au moyen de membranes perforees
DE102004038359A1 (de) Paralleles Hochdurchsatz-Einzelmolekül-Sequenzierungsverfahren
EP1458892B1 (fr) Procede de sequen age multiplex base sur le principe de l'evanescence
DE10224339A1 (de) Verfahren zur hochparallelen Nukleinsäuresequenzierung
DE10065626A1 (de) Einzelmolekül-Sequenzierungsverfahren
EP1816217B1 (fr) Méthode pour la détection d'une pluralité d'acides nucléiques cibles
DE60223532T2 (de) Nachweis von Einzelnukleotidpolymorphismen durch Einzelmolekülanalyse
DE10316159A1 (de) 5`-3`-Exonuklease Assay zur Bestimmung der Konzentration von Nukleinsäuren
EP1280939A2 (fr) Procede de detection de polynucleotides
DE19960398B4 (de) Verfahren und elektrochemischer Sensor mit geheizten Elektroden für die biochemische Analytik, insbesondere zur Untersuchung von Hybridisierungsvorgängen der Nucleinsäuren
DE10065631A1 (de) Nachweis von Nukleinsäure- Polymorphismen
DE102014207183A1 (de) Sequenziervorrichtung zum elektronischen Einzelmolekül-Sequenzieren eines biologischen Makromoleküls
EP3790992A1 (fr) Dispositif microfluidique et procédé de sequençage de nanostructures de brins nucléotidiques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021219

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20070928

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110104